To further establish the effects of RSPO1 p.R219W mutation on obesity in vivo, we thus produced a p.R219W point mutation knock‐in mouse model using the CRISPR–Cas9 approach, to recapitulate the homologous mutation that occurs in humans faithfully. The gene discussed is RSPO1; the disease is obesity due to melanocortin 4 receptor deficiency.